Antimicrobial Resistance and Infection Control | |
Risk factors for Candida colonization and Co-colonization with multi-drug resistant organisms at admission | |
Danielle M. Schulte2  Ajay Sethi1  Ronald Gangnon1  Megan Duster2  Dennis G. Maki2  Nasia Safdar3  | |
[1] Department of Population Health Sciences, University of Wisconsin – Madison School of Medicine and Public Health, Madison, WI, USA | |
[2] Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA | |
[3] William S. Middleton Memorial Veterans Affairs Medical Center, Madison, WI, USA | |
关键词: Healthcare-associated infections; Multi-drug resistant organisms; Colonization; Candida; | |
Others : 1234946 DOI : 10.1186/s13756-015-0089-9 |
|
received in 2015-06-29, accepted in 2015-11-01, 发布年份 2015 |
【 摘 要 】
Introduction
Candida species are major causes of healthcare-associated infections with colonization preceding infection. Understanding risk factors for colonization by Candida species is important in prevention. However, data on risk factors for colonization by Candida species alone or with other healthcare-associated pathogens is limited.
Methods
From 2002 to 2006, 498 patients were enrolled into a prospective cohort study at our institution. Surveillance perirectal, nasal and skin swab samples were obtained upon enrollment. Samples were cultured for the presence of Candida species, Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Enterococcus, and Resistant Gram Negative organisms. Data on demographics, comorbidities, device use, and antibiotic use were also collected for each subject and analyzed using univariate and multivariate logistic regression.
Results
Factors associated with Candida colonization at admission in univariate analysis included ambulatory status, a history of Candida colonization and the use of antibiotics prior to enrollment. In multivariate analysis, ambulatory status (odds ratio; OR = 0.45, 95 % CI: 0.27–0.73) and fluroquinolone use (OR = 3.01, 95 % CI: 1.80–5.01) were associated with Candida colonization at admission. Factors predicting Candida co-colonization with one or more MDROs at admission in univariate analysis included, older age, malnutrition, days spent in an ICU in the 2 years prior to enrollment, a history of MRSA colonization, and using antibiotics prior to enrollment. In multivariate analysis malnutrition (OR = 3.97, 95 % CI: 1.80–8.78) a history of MRSA (OR = 5.51, 95 % CI: 1.89–16.04) and the use of macrolides (OR = 3.75, 95 % CI: 1.18–11.93) and other antibiotics (OR = 4.94, 95 % CI: 1.52–16.03) were associated with Candida co-colonization at admission.
Discussion
Antibiotic use was associated with an increased risk of colonization by Candida species alone and in conjunction with other multidrug-resistant organisms (MDROs). Antibiotic stewardship may be an important intervention for preventing colonization and subsequent infection by Candida and other MDROs.
【 授权许可】
2015 Schulte et al.
【 参考文献 】
- [1]Healthcare-associated Infections (HAIs). Centers for Disease Control and Prevention. 09 Dec. 2013. Web. 25 Feb. 2014.
- [2]Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA et al.. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Rep. 2007; 122:160-6.
- [3]Kett DH, Azoulay E, Echeverria PM, Vincent JL. Candida Bloodstream Infections in Intensive Care Units: Analysis of the Extended Prevalence of Infection in Intensive Care Unit Study. Crit Care Med. 2011; 39(4):665-70.
- [4]Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA. NHSN Annual Update: Antimicrobial-resistant Pathogens Associated with Healthcare-associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29:996-1011.
- [5]Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JG et al.. Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization. Emerg Infect Dis. 2005; 11(10):1539-44.
- [6]Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the Treatment of Multidrug-Resistant, Gram-Positive Infections: Experience from a Compassionate-Use Program. Clin Infect Dis. 2003; 36(2):159-68.
- [7]Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G et al.. Efficacy and Safety of Tigecycline Compared with Vancomycin or Linezolid for Treatment of Serious Infections with Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci: a Phase 3, Multicentre, Double-Blind, Randomized Study. J Antimicrobial Chemotherapy. 2008; 62(1):i17-28.
- [8]Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-Kingdom Interactions: Candida albicans and Bacteria”. FEMS Microbiol. 2009; 299:1-8.
- [9]Viale P. Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit. Drugs. 2009; 69:51-7.
- [10]Setia U, Serventi I, Lorenz P. Nosocomial Infections Among Patients in a Long-term Care Facility: Spectrum, Prevalence, and Risk Factors. Am J Infect Control. 1985; 13:57-62.
- [11]Dalrymple LS, Johansen KL, Chertow GM, Cheng SC, Grimes B, Gold EB et al.. Infection-Related Hospitalization in Older Patients With ESRD. Am J Kidney Dis. 2010; 56(3):522-30.
- [12]Guo H, Liu J, Collins AJ, Foley RN. Pneumonia in Incident Dialysis Patients – The United States Renal Data System. Nephrol Dial Transplant. 2008; 23(2):680-6.
- [13]Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States Dialysis Population, 1991 to 1999”. J Am Soc Nephrol. 2004;15(4):1038–45.
- [14]Magnussen MH, Robb SS. Nosocomial Infections in a Long-term Care Facility. Am J Infect Control. 1980; 8(1):12-7.
- [15]Giraldo P, Von Nowaskonski A, Gomes FAM, Linhares I, Neves NA, Witkin SS. Vaginal Colonization by Candida in Asymptomatic Women With and Without a History of Recurrent Vulvovaginal Candidiasis. Obstet Gynecol. 2000; 95(3):413-6.
- [16]Mojazi AH, Frandah W, Colmer-Hamood J, Raj R, Nugent K. Risk Factors of Candida Colonization in the Oropharynx of Patients Admitted to an Intensive Care Unit. J de Mycologie Medicale. 2012; 22:301-7.
- [17]Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, Johnson WD. Malnutrition as a Risk Factor for Severe Visceral Leishaniasis. J Infect Dis. 1987; 156(6):1030-3.
- [18]Otter JA, Herdman MT, Williams B, Tosas O, Edgeworth JD, French GL. Low Prevalence of Meticillin-Resistant Staphylococcus aureus Carriage at Hospital Admission: Implications for Risk-Factor-Based vs. Universal Screening. J Hospital Infection. 2013; 83:114-21.
- [19]Everhart JS, Altneu E, Calhoun JH. Medical Comorbidities are Independent Preoperative Risk Factors for Surgical Infection after Total Joint Arthroplasty. Clin Orthop Relat Res. 2013; 471(10):3112-9.
- [20]McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS. A Systematic Literature Review and Meta-Analysis of Factors Associated with Methicillin-Resistant Staphylococcus aureus Colonization at Time of Hospital or Intensive Care Unit Admission. Infect Control Hosp Epidemiol. 2013; 34(10):1077-86.
- [21]Samonis G, Anastassiadou H, Dassiou M, Tselentis Y, Bodey GP. Effects of Broad-Spectrum antibiotics on Colonization of Gastrointestinal Tracts of Mice by Candida Albicans. Antimicrob Agents Chemother. 1994; 38(3):602-3.
- [22]Krause R, Schwab E, Bachhiesl D, Daxböck F, Wenisch C, Krejs GJ et al.. Role of Candida in Antibiotic-Associated Diarrhea”. J Infect Dis. 2001; 184(8):1065-9.
- [23]Pirotta MV, Garland SM. Genital Candida Species Detected in Samples from Women in Melbourne Australia, Before and After Treatment With Antibiotics. J Clin Microbiol. 2006; 44(9):3213-7.
- [24]Huppert M, MacPherson DA, Cazin J. Pathogenesis of Candida albicans Infection Following Antibiotics Therapy. J Bacteriol. 1953; 65(2):171-6.
- [25]Spinillo A, Capuzzo E, Acciano S, De Santolo A, Zara F. Effect of Antibiotic Use on the Prevalence of Symptomatic Vulvovaginal Candidiasis. Am J Obstet Gynecol. 1999; 180(1):14-7.